BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27211211)

  • 1. 3-Iodo-4-aminoquinoline derivative sensitises resistant strains of Plasmodium falciparum to chloroquine.
    Edaye S; Tazoo D; Bohle DS; Georges E
    Int J Antimicrob Agents; 2016 Jun; 47(6):482-5. PubMed ID: 27211211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
    Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL
    Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.
    Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E
    ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of Plasmodium falciparum.
    Manohar S; Khan SI; Rawat DS
    Chem Biol Drug Des; 2013 May; 81(5):625-30. PubMed ID: 23331618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
    Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity.
    Sparatore A; Basilico N; Parapini S; Romeo S; Novelli F; Sparatore F; Taramelli D
    Bioorg Med Chem; 2005 Sep; 13(18):5338-45. PubMed ID: 16054368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of benzhydryl-based antiplasmodial agents possessing Plasmodium falciparum chloroquine resistance transporter (PfCRT) inhibitory activity.
    Relitti N; Federico S; Pozzetti L; Butini S; Lamponi S; Taramelli D; D'Alessandro S; Martin RE; Shafik SH; Summers RL; Babij SK; Habluetzel A; Tapanelli S; Caldelari R; Gemma S; Campiani G
    Eur J Med Chem; 2021 Apr; 215():113227. PubMed ID: 33601312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Halo Chloroquine Derivatives Overcome Plasmodium falciparum Chloroquine Resistance Transporter-Mediated Drug Resistance in P. falciparum.
    Edaye S; Tazoo D; Bohle DS; Georges E
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7891-3. PubMed ID: 26438496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.
    Kalkanidis M; Klonis N; Tschan S; Deady LW; Tilley L
    Biochem Pharmacol; 2004 Apr; 67(7):1347-53. PubMed ID: 15013850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain.
    Sinha M; Dola VR; Agarwal P; Srivastava K; Haq W; Puri SK; Katti SB
    Bioorg Med Chem; 2014 Jul; 22(14):3573-86. PubMed ID: 24906512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.
    Daher W; Biot C; Fandeur T; Jouin H; Pelinski L; Viscogliosi E; Fraisse L; Pradines B; Brocard J; Khalife J; Dive D
    Malar J; 2006 Feb; 5():11. PubMed ID: 16464254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-aminoquinolines active against chloroquine-resistant Plasmodium falciparum: basis of antiparasite activity and quantitative structure-activity relationship analyses.
    Hocart SJ; Liu H; Deng H; De D; Krogstad FM; Krogstad DJ
    Antimicrob Agents Chemother; 2011 May; 55(5):2233-44. PubMed ID: 21383099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synergistic interaction of potent 4-aminoquinolines in combination with dihydroartemisinin against chloroquine-resistant Plasmodium falciparum.
    Agarwal D; Singh S; Gupta RD; Awasthi SK
    Acta Trop; 2019 Nov; 199():105109. PubMed ID: 31351071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites.
    Singh S; Agarwal D; Sharma K; Sharma M; Nielsen MA; Alifrangis M; Singh AK; Gupta RD; Awasthi SK
    Eur J Med Chem; 2016 Oct; 122():394-407. PubMed ID: 27394399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Fitness Cost-Neutral Mutant PfCRT Conferring P. falciparum 4-Aminoquinoline Drug Resistance Is Accompanied by Altered Parasite Metabolism and Digestive Vacuole Physiology.
    Gabryszewski SJ; Dhingra SK; Combrinck JM; Lewis IA; Callaghan PS; Hassett MR; Siriwardana A; Henrich PP; Lee AH; Gnädig NF; Musset L; Llinás M; Egan TJ; Roepe PD; Fidock DA
    PLoS Pathog; 2016 Nov; 12(11):e1005976. PubMed ID: 27832198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.
    Edaye S; Reiling SJ; Leimanis ML; Wunderlich J; Rohrbach P; Georges E
    Mol Biochem Parasitol; 2014 Jun; 195(1):34-42. PubMed ID: 24914817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum.
    Bray PG; Deed S; Fox E; Kalkanidis M; Mungthin M; Deady LW; Tilley L
    Biochem Pharmacol; 2005 Oct; 70(8):1158-66. PubMed ID: 16139253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum.
    Sanchez CP; Stein WD; Lanzer M
    Trends Parasitol; 2007 Jul; 23(7):332-9. PubMed ID: 17493873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine.
    Warhurst DC
    Malar J; 2003 Sep; 2():31. PubMed ID: 14599295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in genotypes of Plasmodium falciparum human malaria parasite following withdrawal of chloroquine in Tiwi, Kenya.
    Mang'era CM; Mbai FN; Omedo IA; Mireji PO; Omar SA
    Acta Trop; 2012 Sep; 123(3):202-7. PubMed ID: 22641431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.